Polarean Imaging plc (AIM: POLX), the medical imaging technology company, with a proprietary drug device combination product for the magnetic resonance imaging (MRI) market, announces that it has issued 705,040 new ordinary shares of £0.00037 each in the capital of the Company (“Ordinary Shares”) at exercise price of 15 pence per share
April 2, 2019
· 2 min read